Robert Schou Pedersen

828 total citations
35 papers, 447 citations indexed

About

Robert Schou Pedersen is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Robert Schou Pedersen has authored 35 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 17 papers in Genetics and 10 papers in Oncology. Recurrent topics in Robert Schou Pedersen's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Robert Schou Pedersen is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Robert Schou Pedersen collaborates with scholars based in Denmark, Sweden and Serbia. Robert Schou Pedersen's co-authors include Peter de Nully Brown, Per Trøllund Pedersen, Walter K. Kremers, Ross Dierkhising, Christian Bjørn Poulsen, Robin Patel, Mikael Frederiksen, Henrik Frederiksen, Olav J. Bergmann and Lisbeth Enggaard and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Robert Schou Pedersen

31 papers receiving 444 citations

Peers

Countries citing papers authored by Robert Schou Pedersen

Since Specialization

Citations

This map shows the geographic impact of Robert Schou Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schou Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schou Pedersen more than expected).

Fields of papers citing papers by Robert Schou Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schou Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schou Pedersen. The network helps show where Robert Schou Pedersen may publish in the future.

Co-authorship network of co-authors of Robert Schou Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schou Pedersen. A scholar is included among the top collaborators of Robert Schou Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schou Pedersen. Robert Schou Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study 2025 ·PubMed ·(unknown), (unknown), (unknown), Elfriede Dall, Sebastian Rasch, (unknown), Simon Husby, (unknown), Michael Roost Clausen, Thomas Stauffer Larsen, Jacob Haaber Christensen, Robert Schou Pedersen, Mikael Frederiksen, Mats Jerkeman, Christian Bjørn Poulsen, (unknown), Peter C. Brown, Tarec Christoffer El‐Galaly, Kirsten Grønbæk	0
2	Effectiveness of R‐CHOP versus R‐CHOEP for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study 2024 ·European Journal Of Haematology ·(unknown), Lasse Jakobsen, Sandra Eloranta, Karin E. Smedby, Robert Schou Pedersen, Judit Jørgensen, Michael Roost Clausen, Peter de Nully Brown, Anne Ortved Gang, (unknown), Thomas Stauffer Larsen, Mats Jerkeman, Tarec Christoffer El‐Galaly	2
3	A Real‐World Data‐Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B‐Cell Lymphoma Patients 2024 ·European Journal Of Haematology ·Jelena Jelicic, (unknown), Zoran Bukumirić, (unknown), Michael Roost Clausen, (unknown), Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen	1
4	Validation of prognostic models in elderly patients with diffuse large B-cell lymphoma in a real-world nationwide population-based study – development of a clinical nomogram 2024 ·Annals of Hematology ·Jelena Jelicic, (unknown), Zoran Bukumirić, (unknown), (unknown), Michael Roost Clausen, (unknown), Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen	2
5	The long‐term risk of immune‐related conditions in survivors of diffuse large B‐cell lymphoma: A Danish nationwide registry study 2024 ·SHILAP Revista de lepidopterología ·Lars Pedersen, (unknown), Jonas Jensen, (unknown), Peter de Nully Brown, Judit Jørgensen, Thomas Stauffer Larsen, Christian Bjørn Poulsen, Michael Roost Clausen, Robert Schou Pedersen, Anne Ortved Gang, (unknown), Salome Kristensen, Lene Dreyer, Tarec Christoffer El‐Galaly, Lasse Hjort Jakobsen	1
6	Identifying Trial-Eligible High- and High-Intermediate Risk Patients with Diffuse Large B-Cell Lymphoma Using Prognostic Models: A Real-Life Comparative Analysis of IPI, aaIPI and NCCN-IPI from Danish Study Group 2024 ·Blood ·Jelena Jelicic, (unknown), Zoran Bukumirić, (unknown), Michael Roost Clausen, (unknown), Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, (unknown), Thomas Stauffer Larsen	0
7	Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study 2023 ·Clinical Epidemiology ·(unknown), Lasse Hjort Jakobsen, Kristian Kragholm, Joachim Bæch, Mikkel Porsborg Andersen, Jakob Madsen, Judit Jørgensen, Michael Roost Clausen, Robert Schou Pedersen, (unknown), Thomas Stauffer Larsen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Kirsten Fonager, Tarec Christoffer El‐Galaly, Marianne Tang Severinsen	4
8	Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study 2023 ·Journal of Geriatric Oncology ·(unknown), Lasse Hjort Jakobsen, Boris Modrau, (unknown), Kristian Kragholm, Judit Jørgensen, Michael Roost Clausen, Robert Schou Pedersen, (unknown), Thomas Stauffer Larsen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El‐Galaly, Marianne Tang Severinsen	2
9	Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models 2023 ·Blood Cancer Journal ·Jelena Jelicic, (unknown), Zoran Bukumirić, Michael Roost Clausen, (unknown), Robert Schou Pedersen, Christian Bjørn Poulsen, Peter de Nully Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen	23
10	Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy 2022 ·Blood Advances ·Joachim Bæch, Marianne Tang Severinsen, (unknown), Henrik Frederiksen, Peter Vestergaard, Christian Torp‐Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin E. Smedby, Sandra Eloranta, Lasse Jakobsen, Tarec Christoffer El‐Galaly	2
11	Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation 2022 ·European Journal Of Haematology ·(unknown), (unknown), (unknown), Martin Bøgsted, Henrik Gregersen, Robert Schou Pedersen, (unknown), (unknown), Per Trøllund Pedersen, Niels Abildgaard, Emil Hermansen, Annette Juul Vangsted, Marianne Tang Severinsen	2
12	Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark 2022 ·Blood Cancer Journal ·Lasse Hjort Jakobsen, (unknown), Marianne Tang Severinsen, Joachim Bæch, Kristian Kragholm, Ingrid Glimelius, Anne Ortved Gang, Judit Jørgensen, Henrik Frederiksen, Christian Bjørn Poulsen, Michael Roost Clausen, Per Trøllund Pedersen, Robert Schou Pedersen, Christian Torp‐Pedersen, Sandra Eloranta, Tarec Christoffer El‐Galaly	6
13	<p>Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy</p> 2019 ·Clinical Epidemiology ·Michael Roost Clausen, Matthew J. Maurer, Sinna Pilgaard Ulrichsen, Thomas Stauffer Larsen, (unknown), Dorthe Rønnov‐Jessen, Brian K. Link, Andrew L. Feldman, Susan L. Slager, Grzegorz S. Nowakowski, Carrie A. Thompson, Per Trøllund Pedersen, Jakob Madsen, Robert Schou Pedersen, Jette Sønderskov Gørløv, James R. Cerhan, Mette Nørgaard, Francesco d’Amore	7
14	The Danish National Chronic Lymphocytic Leukemia Registry 2016 ·Clinical Epidemiology ·Caspar da Cunha‐Bang, Christian H. Geisler, Lisbeth Enggaard, Christian Bjørn Poulsen, Peter de Nully Brown, Henrik Frederiksen, Olav J. Bergmann, Elisa Jacobsen Pulczynski, Robert Schou Pedersen, (unknown), Ilse Christiansen, Carsten Utoft Niemann	41
15	The Danish National Acute Leukemia Registry 2016 ·Clinical Epidemiology ·Lene Sofie Granfeldt Østgård, Jan Maxwell Nørgaard, Klas Raaschou‐Jensen, Robert Schou Pedersen, Dorthe Rønnov‐Jessen, Per Trøllund Pedersen, Inge Høgh Dufva, Claus Werenberg Marcher, Ove Juul Nielsen, Marianne Tang Severinsen, Lone S. Friis	26
16	The Danish National Multiple Myeloma Registry 2016 ·Clinical Epidemiology ·Peter Gimsing, Morten Orebo Holmström, (unknown), Niels Frost Andersen, Henrik Gregersen, Robert Schou Pedersen, Torben Plesner, Per Trøllund Pedersen, Mikael Frederiksen, Ulf Christian Frølund, Carsten Helleberg, Annette Juul Vangsted, Peter de Nully Brown, Niels Abildgaard	46
17	Danish National Lymphoma Registry 2016 ·Clinical Epidemiology ·Bente Arboe, Pär Josefsson, Judit Jørgensen, Jacob Haaber, Paw Jensen, Christian Bjørn Poulsen, Dorthe Rønnov‐Jessen, Robert Schou Pedersen, Per Trøllund Pedersen, Mikael Frederiksen, Michael Pedersen, Peter de Nully Brown	47
18	A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry 2015 ·Leukemia & lymphoma ·Anne Ortved Gang, Michael Pedersen, Francesco d’Amore, Lars Møller Pedersen, Bo Amdi Jensen, Paw Jensen, Michael Møller, Hans Torben Mourits‐Andersen, Robert Schou Pedersen, Tobias Wirenfeldt Klausen, Peter de Nully Brown	20
19	CPC-114 Prevalence and Management of Drug-Related Problems in an Intensive Care Unit 2013 ·European Journal of Hospital Pharmacy ·(unknown), (unknown), (unknown), Robert Schou Pedersen, Espen Molden	2
20	Varicella zoster virus‐associated disease in adult kidney transplant recipients: incidence and risk‐factor analysis 2008 ·Transplant Infectious Disease ·(unknown), Robert Schou Pedersen, Ross Dierkhising, Walter K. Kremers, Robin Patel	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact